Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Medigene AG: A reportable insider transaction was published on 16th May 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 16th May 2024,
The Insider Transaction was made by Ho, Dr. Selwyn 
. The transaction toke place on 10th May 2024. . The aggregated volume was 60.000,00 EUR, based on an average price of 1,20 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 15th May 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 15th May 2024,
The Insider Transaction was made by Zettlmeissl, Dr. Gerd . The transaction toke place on 13th May 2024. . The aggregated volume was 12.000,00 EUR, based on an average price of 1,20 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 15th May 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th May 2024,
The Insider Transaction was made by Ho, Dr. Selwyn . The transaction toke place on 13th May 2024. . The aggregated volume was 32.400,00 EUR, based on an average price of 1,20 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 15th May 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 15th May 2024,
The Insider Transaction was made by Mathias, Dr. Frank . The transaction toke place on 13th May 2024. . The aggregated volume was 6.963,60 EUR, based on an average price of 1,20 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 8th May 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 8th May 2024,
The Insider Transaction was made by Man, Dr. Anthony . The transaction toke place on 8th May 2024. The order was executed at the trading place Berlin. . The aggregated volume was 3.875,00 EUR, based on an average price of 1,55 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 2nd May 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 2nd May 2024,
The Insider Transaction was made by Zettlmeissl, Dr. Gerd . The transaction toke place on 30th April 2024. The order was executed at the trading place Frankfurt, MIC XFRA. . The aggregated volume was 850,00 EUR, based on an average price of 0,02 EUR. The nature of the Investment was not specified.
Medigene AG: A reportable insider transaction was published on 11th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 11th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 10th July 2023. The order was executed at the trading place London. . The aggregated volume was 16.553,24 EUR, based on an average price of 1,79 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 7th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 6th July 2023. The order was executed at the trading place London. . The aggregated volume was 2.426,25 EUR, based on an average price of 1,88 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 6th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 6th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 5th July 2023. The order was executed at the trading place London. . The aggregated volume was 2.731,53 EUR, based on an average price of 1,90 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 5th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 4th July 2023. The order was executed at the trading place London. . The aggregated volume was 11.460,00 EUR, based on an average price of 1,91 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 5th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 4th July 2023. The order was executed at the trading place London. . The aggregated volume was 11.460,00 EUR, based on an average price of 1,91 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 5th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 4th July 2023. The order was executed at the trading place London. . The aggregated volume was 11.460,00 EUR, based on an average price of 1,91 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 5th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 4th July 2023. The order was executed at the trading place London. . The aggregated volume was 11.460,00 EUR, based on an average price of 1,91 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 5th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 4th July 2023. The order was executed at the trading place London. . The aggregated volume was 11.460,00 EUR, based on an average price of 1,91 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 5th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 4th July 2023. The order was executed at the trading place London. . The aggregated volume was 11.460,00 EUR, based on an average price of 1,91 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 5th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 4th July 2023. The order was executed at the trading place London. . The aggregated volume was 11.460,00 EUR, based on an average price of 1,91 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 5th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 4th July 2023. The order was executed at the trading place London. . The aggregated volume was 11.460,00 EUR, based on an average price of 1,91 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 5th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 4th July 2023. The order was executed at the trading place London. . The aggregated volume was 11.460,00 EUR, based on an average price of 1,91 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 5th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 4th July 2023. The order was executed at the trading place London. . The aggregated volume was 11.460,00 EUR, based on an average price of 1,91 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 5th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th July 2023,
The Insider Transaction was made by Ho, Dr Selwyn . The transaction toke place on 4th July 2023. The order was executed at the trading place London. . The aggregated volume was 11.460,00 EUR, based on an average price of 1,91 EUR. The nature of the Investment was Buy.
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Equity Story | 0 | - | - | EQS |
| Corporate Research | 0 | - | - | Corporate Research |
| Short Seller (DE) | 7 | 2nd April 2019 | GSA Capital Partners LLP | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.